Insider

Insider #4: Nexus's $126m fund II + BCI cost estimates & predictions + commercializing neural data + more

Nexus Neurotech's $126m Fund II, BCI cost estimates, Commercial Strategy for Foundation Models, A Summer Mixer, & More!

Apr 23 •

Neurotech Insider #3: BCI BS, Commercial Culture, Recycled Innovation, Join my Investor Rolodex, and More

Caveat Emptor: Not All BCI are Created Equal!

Mar 14 •

Neurotech Insider #2: Precision Neuroscience's CEO Michael Mager on BCI Valuations (and more)

Plus: TMS Perceptions, HIFU vs DBS, next-gen DBS, Cryptic Crypto, New Deals,

Feb 13 •

Welcome to Neurotech Insider!

An Update on Your Membership

Jan 9 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts